RAPID: The effect of contact network structure on the spread of COVID-19: balancing disease mitigation and socioeconomic well-being
Division of Environmental Biology
People: Eva Enns, Meggan Craft
2020 – 2021
Eva Enns
Associate Professor
Education
Affiliations
Bio
Preferred Pronouns
Personal Academic Website
Research/Topics of Interest
Pathogens/Diseases of Main Interest/Expertise
Countries of Work/Collaboration
Projects
Papers
Alarid-Escudero F, Krijkamp E, Enns EA, Yang A, Hunink MGM, Pechlivanoglou P, Jalal H. (2022). An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example. Medical decision making : an international journal of the Society for Medical Decision Making
Wheatley MM, Peterson AD, Wolfson J, Hanft J, Rowles D, Blissett T, Enns EA. (2022). Variation in local Ryan White HIV/AIDS program service use and impacts on viral suppression: informing quality improvement efforts. AIDS care
Jenness SM, Le Guillou A, Lyles C, Bernstein KT, Krupinsky K, Enns EA, Sullivan PS, Delaney KP. (2022). The Role of HIV Partner Services in the Modern Biomedical HIV Prevention Era: A Network Modeling Study. Sexually transmitted diseases
Wheatley MM, Knowlton G, Kao SY, Jenness SM, Enns EA. (2022). Cost-Effectiveness of Interventions to Improve HIV Pre-Exposure Prophylaxis Initiation, Adherence, and Persistence among Men Who Have Sex with Men. Journal of acquired immune deficiency syndromes (1999)
Wheatley MM, Knowlton GS, Butler M, Enns EA. (2022). Cost-Effectiveness of HIV Retention and Re-engagement Interventions in High-Income Countries: A Systematic Literature Review. AIDS and behavior
Chantarat T, Enns EA, Hardeman RR, McGovern PM, Myers SL Jr., Dill J. (2022). Occupational Segregation And Hypertension Inequity: The Implication Of The Inverse Hazard Law Among Healthcare Workers. Journal of economics, race, and policy
Alarid-Escudero F, Krijkamp E, Enns EA, Yang A, Hunink MGM, Pechlivanoglou P, Jalal H. (2022). A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example. Medical decision making : an international journal of the Society for Medical Decision Making
Chantarat T, McGovern PM, Enns EA, Hardeman RR. (2022). Predicting the onset of hypertension for workers: does including work characteristics improve risk predictive accuracy?. Journal of human hypertension
Aby ES, Vaughn BP, Enns EA, Rajasingham R. (2022). Cost-effectiveness of fecal microbiota transplantation for first recurrent Clostridioides difficile infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Zhang AZ, Enns EA. (2022). Optimal timing and effectiveness of COVID-19 outbreak responses in China: a modelling study. BMC public health, 22(1)
Groene EA, Boraas C, Smith K, Lofgren S, Rothenberger M, Enns E. (2022). A statewide mixed-methods study of provider knowledge and behavior administering Expedited Partner Therapy for chlamydia and gonorrhea. Sexually transmitted diseases
Popp J, Weinberg DS, Enns E, Nyman JA, Beck JR, Kuntz KM. (2022). Reevaluating the Evidence for Intensive Postoperative Extracolonic Surveillance for Nonmetastatic Colorectal Cancer. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 25(1)
Rao DW, Wheatley MM, Goodreau SM, Enns EA. (2021). Partnership dynamics in mathematical models and implications for representation of sexually transmitted infections: a review. Annals of epidemiology
Malloy GSP, Goldhaber-Fiebert JD, Enns EA, Brandeau ML. (2021). Predicting the Effectiveness of Endemic Infectious Disease Control Interventions: The Impact of Mass Action versus Network Model Structure. Medical decision making : an international journal of the Society for Medical Decision Making
Siriruchatanon M, Liu S, Carlucci JG, Enns EA, Duarte HA. (2021). Addressing Pediatric HIV Pretreatment Drug Resistance and Virologic Failure in Sub-Saharan Africa: A Cost-Effectiveness Analysis of Diagnostic-Based Strategies in Children ≥3 Years Old. Diagnostics (Basel, Switzerland), 11(3)
Cipriano LE, Haddara WMR, Zaric GS, Enns EA. (2021). Impact of university re-opening on total community COVID-19 burden. PloS one, 16(8)
Quan AML, Mah C, Krebs E, Zang X, Chen S, Althoff K, Armstrong W, Behrends CN, Dombrowski JC, Enns E, Feaster DJ, Gebo KA, Goedel WC, Golden M, Marshall BDL, Mehta SH, Pandya A, Schackman BR, Strathdee SA, Sullivan P, Tookes H, Nosyk B, . (2021). Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities. The lancet. HIV
Jenness SM, Knowlton G, Smith DK, Marcus JL, Anderson EJ, Siegler AJ, Jones J, Sullivan PS, Enns E. (2021). A decision analytics model to optimize investment in interventions targeting the HIV PrEP cascade of care. AIDS (London, England)
Caro-Vega Y, Alarid-Escudero F, Enns EA, Sosa-Rubí S, Chivardi C, Piñeirúa-Menendez A, García-Morales C, Reyes-Terán G, Sierra-Madero JG, Ávila-Ríos S. (2021). Retention in Care, Mortality, Loss-to-Follow-Up, and Viral Suppression among Antiretroviral Treatment-Naïve and Experienced Persons Participating in a Nationally Representative HIV Pre-Treatment Drug Resistance Survey in Mexico. Pathogens (Basel, Switzerland), 10(12)
Krijkamp EM, Alarid-Escudero F, Enns EA, Pechlivanoglou P, Hunink MGM, Yang A, Jalal HJ. (2020). A Multidimensional Array Representation of State-Transition Model Dynamics. Medical decision making : an international journal of the Society for Medical Decision Making
Kao SZ, Enns EA. (2020). Follow the Sex: Influence of Network Structure on the Effectiveness and Cost-Effectiveness of Partner Management Strategies for Sexually Transmitted Infection Control. Sexually transmitted diseases, 47(2)
Schwehr NA, Kuntz KM, Enns EA, Shippee ND, Kingwell E, Tremlett H, Carpenter AF, Butler M, . (2020). Informing Medication Discontinuation Decisions among Older Adults with Relapsing-Onset Multiple Sclerosis. Drugs & aging, 37(3)
Rajasingham R, Enns EA, Vaughn BP. (2020). Reply to Author. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Duarte HA, Babigumira JB, Enns EA, Stauffer DC, Shafer RW, Beck IA, Garrison LP Jr., Chung MH, Frenkel LM, Bendavid E. (2020). Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women. EClinicalMedicine, (22)
Schwehr NA, Kuntz KM, Butler M, Enns EA, Shippee ND, Kingwell E, Tremlett H, Carpenter AF, . (2020). Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 26(12)
Alarid-Escudero F, Krijkamp EM, Pechlivanoglou P, Jalal H, Kao SZ, Yang A, Enns EA. (2019). A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling. PharmacoEconomics, 37(11)
Rajasingham R, Enns EA, Khoruts A, Vaughn BP. (2020). Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70(5)
Negoescu DM, Enns EA, Swanhorst B, Baumgartner B, Campbell JP, Osterman MT, Papamichael K, Cheifetz AS, Vaughn BP. (2020). Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort. Inflammatory bowel diseases, 26(1)
Enns EA, Reilly CS, Horvath KJ, Baker-James K, Henry K. (2019). HIV Care Trajectories as a Novel Longitudinal Assessment of Retention in Care. AIDS and behavior, 23(9)
Chehrazi N, Cipriano LE, Enns EA. (2019). Dynamics of Drug Resistance: Optimal Control of an Infectious Disease. Operations research, 67(3)
Alarid-Escudero F, Enns EA, Kuntz KM, Michaud TL, Jalal H. (2019). "Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 22(5)
Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MGM, Pechlivanoglou P. (2018). Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial. Medical decision making : an international journal of the Society for Medical Decision Making, 38(3)
Alarid-Escudero F, MacLehose RF, Peralta Y, Kuntz KM, Enns EA. (2018). Nonidentifiability in Model Calibration and Implications for Medical Decision Making. Medical decision making : an international journal of the Society for Medical Decision Making, 38(7)
Kao SZ, VanderWaal K, Enns EA, Craft ME, Alvarez J, Picasso C, Wells SJ. (2018). Modeling cost-effectiveness of risk-based bovine tuberculosis surveillance in Minnesota. Preventive veterinary medicine, (159)
Lee K, Drekonja DM, Enns EA. (2018). Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 21(3)
VanderWaal K, Enns EA, Picasso C, Alvarez J, Perez A, Fernandez F, Gil A, Craft M, Wells S. (2017). Optimal surveillance strategies for bovine tuberculosis in a low-prevalence country. Scientific reports, 7(1)
Thao V, Enns EA, Patrick SW, Levy R, Kozhimannil KB. Decision Science Can Help Policymakers to Identify and Evaluate Policies to Treat Opioid Use Disorder Among Pregnant Women. Women's health issues : official publication of the Jacobs Institute of Women's Health, 28(1)
Enns EA, Kao SY, Kozhimannil KB, Kahn J, Farris J, Kulasingam SL. (2017). Using Multiple Outcomes of Sexual Behavior to Provide Insights Into Chlamydia Transmission and the Effectiveness of Prevention Interventions in Adolescents. Sexually transmitted diseases, 44(10)
Jalal H, Pechlivanoglou P, Krijkamp E, Alarid-Escudero F, Enns E, Hunink MGM. (2017). An Overview of R in Health Decision Sciences. Medical decision making : an international journal of the Society for Medical Decision Making, 37(7)
Enns EA, Reilly CS, Virnig BA, Baker K, Vogenthaler N, Henry K. (2016). Potential Impact of Integrating HIV Surveillance and Clinic Data on Retention-in-Care Estimates and Re-Engagement Efforts. AIDS patient care and STDs, 30(9)
Enns EA, Brandeau ML. (2015). Link removal for the control of stochastically evolving epidemics over networks: a comparison of approaches. Journal of theoretical biology, (371)
Enns EA, Zaric GS, Strike CJ, Jairam JA, Kolla G, Bayoumi AM. (2016). Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada. Addiction (Abingdon, England), 111(3)
Enns EA, Cipriano LE, Simons CT, Kong CY. (2015). Identifying best-fitting inputs in health-economic model calibration: a Pareto frontier approach. Medical decision making : an international journal of the Society for Medical Decision Making, 35(2)
Enns EA, Mounzer JJ, Brandeau ML. (2012). Optimal link removal for epidemic mitigation: a two-way partitioning approach. Mathematical biosciences, 235(2)
Enns EA, Brandeau ML. (2011). Inferring model parameters in network-based disease simulation. Health care management science, 14(2)
Enns EA, Brandeau ML, Igeme TK, Bendavid E. (2011). Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention. International journal of STD & AIDS, 22(10)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.
MIDAS
Navigation
Menu
Learn More
Menu
Resources
Menu
MIDAS Coordination Center
Contact us: questions@midasnetwork.us
Thank you to NIGMS Grant U24GM132013 for supporting the work at the Coordination Center.
Copyright MIDAS © 2022. All Rights Reserved.